Get started
AFROCENTRIC INV CORP LTDAFROCENTRIC INV CORP LTDAFROCENTRIC INV CORP LTD

AFROCENTRIC INV CORP LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ACT chart


Full chart

ACT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.21 B‬ ZAR
Dividend yield (indicated)
4.18%
Price to earnings Ratio (TTM)
40
Basic EPS (TTM)
0 ZAR
Net income (FY)
‪55.38 M‬ ZAR
Revenue (FY)
‪8.79 B‬ ZAR
Shares float
‪173.58 M‬
Beta (1Y)
0.28

About AFROCENTRIC INV CORP LTD


Sector
Retail Trade
Industry
Drugstore Chains
CEO
Gerald van Wyk
Website
afrocentric.za.com
Headquarters
Johannesburg
Founded
1988
ISIN
ZAE000078416
FIGI
BBG000F2M478
AfroCentric Investment Corp. Ltd. is an investment holding company, which engages in the business of acquiring and holding assets for investment purposes. It operates through the following segments: Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology. The Healthcare SA segment consists of medical scheme administration and health risk management services, of which Medscheme is the biggest contributor. The Healthcare Retail segment refers to pharmaceutical sales and services by Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, Activo Health, and Activo Healthcare Assets Group. The Healthcare Africa segment provides all healthcare services outside of South Africa Namibia and Mauritius. This includes associate earnings in Botswana. The Information Technology segment refers to all information technology services predominantly in South Africa. The company was founded by Michael Ivan Sacks and Jacob Meyer Kahn on February 3, 1988 and is headquartered in Johannesburg, South Africa.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ACT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ACT is 282 ZAC — it has decreased by −3.80% in the past 24 hours. Watch AFROCENTRIC INV CORP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on JSE exchange AFROCENTRIC INV CORP LTD stocks are traded under the ticker ACT.
ACT stock has fallen by −3.80% compared to the previous week, the month change is a −4.89% fall, over the last year AFROCENTRIC INV CORP LTD has showed a −15.57% decrease.
ACT reached its all-time high on Feb 2, 2017 with the price of 695 ZAC, and its all-time low was 98 ZAC and was reached on Jul 9, 2008. View more price dynamics on ACT chart.
See other stocks reaching their highest and lowest prices.
ACT stock is 12.65% volatile and has beta coefficient of 0.28. Track AFROCENTRIC INV CORP LTD stock price on the chart and check out the list of the most volatile stocks — is AFROCENTRIC INV CORP LTD there?
Yes, you can track AFROCENTRIC INV CORP LTD financials in yearly and quarterly reports right on TradingView.
AFROCENTRIC INV CORP LTD is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ACT net income for the last half-year is ‪−118.38 M‬ ZAR, while the previous report showed ‪173.76 M‬ ZAR of net income which accounts for −168.13% change. Track more AFROCENTRIC INV CORP LTD financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFROCENTRIC INV CORP LTD EBITDA is ‪889.95 M‬ ZAR, and current EBITDA margin is 10.12%. See more stats in AFROCENTRIC INV CORP LTD financial statements.
Like other stocks, ACT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFROCENTRIC INV CORP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AFROCENTRIC INV CORP LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AFROCENTRIC INV CORP LTD stock shows the sell signal. See more of AFROCENTRIC INV CORP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.